Status:

COMPLETED

Study to Evaluate Potential Decrease in Hospitalization Events, Time Between Events, and Increasing Longevity in Patients With Symptomatic Heart Failure (0954-948)

Lead Sponsor:

Organon and Co

Conditions:

Heart Failure

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

This is a multicenter study to evaluate potential decrease in hospitalization events and time between events and increasing longevity in patients with symptomatic congestive heart failure and intolera...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Symptomatic heart failure with known or recently diagnosed intolerance of treatment with first-line medication for heart failure
  • May or may not be receiving an alternative and/or additional drug treatment

Exclusion

    Key Trial Info

    Start Date :

    December 19 2001

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    May 13 2009

    Estimated Enrollment :

    3834 Patients enrolled

    Trial Details

    Trial ID

    NCT00090259

    Start Date

    December 19 2001

    End Date

    May 13 2009

    Last Update

    May 16 2024

    Active Locations (0)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 0 (0 locations)

    No Results Found

    We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.